Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar's(TM) Ability to Inhibit DeUbiquitinating ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

A comprehensive study shows that women with endometriosis have a 30-80% increased risk for autoimmune diseases like ...

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

From new cancer therapies to innovative military health care and technology, Harvard's cutting-edge projects are in jeopardy ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the ...

The risk of MS is significantly higher in people with a specific gene variant called HLA-E*01:01 and a history of mono, a study found.

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Having higher numbers of particular gut microbes might put you at a higher risk of developing multiple sclerosis (MS), a new ...

Tolebrutinib did not show superiority over Aubagio (teriflunomide) in reducing relapse rates or MRI-detected inflammatory ...

HIGHER lesion burden in the uncinate fasciculus (UF), a key brain pathway linking emotional regulation regions, is associated with increased anxiety severity in multiple sclerosis (MS) patients, ...